Pre-exposure prophylaxis for HIV prevention in Europe – the status quo
A new ECDC Evidence Brief summarises many of the key issues across Europe regarding implementation of PrEP and provides some options for action. It draws on country data reported to ECDC for Dublin Declaration monitoring in 2016.
Pre-exposure prophylaxis for HIV in Europe
The use of pre-exposure prophylaxis (PrEP) as an HIV prevention strategy, particularly among men who have sex with men (MSM) as well as other population groups at higher risk of HIV infection, has been receiving more and more attention during 2014. Preliminary results of clinical trials and research studies suggest that it could be an effective HIV prevention tool for Europe.
Pre-exposure prophylaxis to prevent HIV among MSM in Europe
The results of two clinical studies, PROUD and IPERGAY, suggests that the use of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM) is an effective HIV prevention tool for Europe.
The benefits of HIV treatment: undetectable means you do not pass on the virus
Since its introduction in the 1990s, the main aim of combination antiretroviral therapy (ART) for HIV has been to halt the progression of the infection, maintaining the health of the HIV-positive person taking treatment. In addition to this, the impact of treatment as prevention has been well described.
Comprehensive Approach to Disease Prevention in the context of Sexual HealthArchived
In an expert meeting in Stockholm, identified synergies and gaps in the availability of sexual health data, programmes, initiatives and policies across Europe and possibilities for future work will be discussed.
Combating HIV and TB through a joint regional action - Northern Dimension Partnership on Public Health and Social Well-being
The aim of this side event was to develop and support effective country and regional responses to further improve the current HIV and tuberculosis situations and reduce their impacts on human lives, economy and society.